Antiischemic therapy in patients with coronary heart disease living in long-term care

Pharmacotherapy

Volumn 19, Issue 5, 1999, Pages 627-634

  Lapane, Kate L ^a,e   Barbour, Marilyn M ^b,c   Van Haaren, Anne ^b   Gambassi, Giovanni ^a,d  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^d CATHOLIC UNIVERSITY   (Italy)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRATE;

AGED; ARTICLE; COGNITION; DAILY LIFE ACTIVITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSING HOME;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; COGNITION; CORONARY DISEASE; DATA COLLECTION; FEMALE; HUMANS; ISCHEMIA; LONG-TERM CARE; MALE; NITRATES; PHYSICAL FITNESS; REGRESSION (PSYCHOLOGY); SEX FACTORS;

EID: 0032954837     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.8.627.31523     Document Type: Article

References (56)

1. Olson H, Aronow W. Medical management of stable angina and unstable angina in the elderly with coronary artery disease. Clin Geriatr Med 1996;12:121-38.
2. Rosamond WD, Chambless LE, Folsom AF, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339;861-7.
3. Harlan WR. Economic considerations that influence health policy and research. Hypertension 1989;13:II58-63.
4. Wenger N, Orourke R, Marcus F. The care of elderly patients with cardiovascular disease. Ann Intern Med 1988;109:425-8.
5. Pepine C. Prognostic implications of silent myocardial ischemia. N Engl J Med 1996;334:113-15.
6. Cohn P. What silent ischemia is masking. Patient Care 1996;30:55-6.
7. Mehta J. Emerging options in the management of myocardial ischemia. Am J Cardiol 1994;73:18a-27.
8. Goldstein S. Beta-blockers in hypertensive and coronary heart disease. Arch Intern Med 1996;156:1267-77.
9. Sial SH, Malone ML, Freeman JE, et al. Beta blocker use in the treatment of community hospital patients after myocardial infarction. J Gen Intern Med 1994;9:599-605.
10. Anderson J. Medical therapy for elderly patients who have had myocardial infarction: too little to late in life? Ann Intern Med 1996;124:335-8.
11. Mendelson G, Aronow W. Underutilization of beta-blockers in older patients with prior myocardial infarction or coronary artery disease in an academic, hospital-based geriatrics practice J Am Geriatr Soc 1998;279:481-3.
12. Gurwitz J, Gore J, Goldberg R, et al. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med 1996;124:283-94.
13. Giugliano R, Camargo C, Lloyd-Jones DM, et al. Elderly patients receive less aggressive medical and invasive management of unstable angina. Arch Intern Med 1998;158:1113-20.
14. Pepine C, Cohn P, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The atenolol silent ischemia study (ASIST) Circulation 1994;90:762-8.
15. Pepine CJ, Geller NL, Knatterud GL, et al. The asymptomatic cardiac ischemia pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol 1994;24:1-10.
16. Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990;30:293-7.
17. Bernabei R, Gambassi G, Mor V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc 1998;46:250-2.
18. Bernabei R, Gambassi G, Lapane K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol 1999;54A(1):M25-33.
19. Gambassi G, Landi F, Peng L, et al. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care 1998;36:167-79.
20. Morris JN, Fries BE, Mehr DR, et al. MDS cognitive performance scale. J Gerontol 1994;49:M174-82.
21. Mor V, Branco K, Fleishman J, et al. The structure of social engagement among nursing home residents. J Gerontol 1995;50:P1-8.
22. Anonymous. Minimum data set plus training manual. Natick, MA: Eliot Press, 1991.
23. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the minimum data set for nursing home resident assessment and care screening (MDS) Gerontologist 1995;2:172-8.
24. Landi F, Gambassi G, Lapane K, et al. Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord 1998;9:347-56.
25. Gambassi G, Landi F, Lapane KL, Sgadari A, Mor V, Bernabei R. Is drug use by the elderly with cognitive impairment influenced by type of dementia? Pharmacotherapy 1999;19(4):430-6.
26. Kannel WB, Vokonas PS. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women. Ann Epidemiol 1992;2:5-14.
27. Tresch DD, Aronow WS. Clinical manifestations and diagnosis of coronary artery disease. Clin Geriatr Med 1996;12:89-100.
28. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the cardiovascular health study: the CHS collaborative research group. Stroke 1992;23:1752-60.
29. Rapaport E, Gheorghiade M. Pharmacologic therapies after myocardial infarction. AmJ Med 1996;101:61s-70.
30. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-14.
31. Norwegian Multicenter Study Group. Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
32. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-21.
33. Haim M, Shotan A, Boyko V, et al. Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. Am J Cardiol 1998;81:1455-60.
34. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish verapamil infarction trial (DAVIT II) and other recent studies. AmJ Cardiol 1991;67:1295-7.
35. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989;299:1187-92.
36. Furberg CD, Psaty BM, Meyer JV. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
37. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-5.
38. Alderman MH, Cohen H, Roque R, Madhaven S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997;349:594-8.
39. Pahor M, Guralnik JM, Corti MC, Foley JD, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medication in older persons. J Am Geriatr Soc 1995;43:1191-7.
40. Aronow WS. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc 1996;44:1075-7.
41. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA, National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project. JAMA 1998;280:623-9.
42. Agusti A, Arnau JM, Laporte JR. Clinical trials versus clinical practice in the secondary prevention of myocardial infarction. Eur J Clin Pharmacol 1994;46:95-9.
43. Woods KL, Ketley D, Lowy A, et al. Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European secondary prevention study group. Eur Heart J 1998;19:74-9.
44. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
45. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed β-blockers. JAMA 1986;255:357-60.
46. Bright RA, Everitt DE. β-Blockers and depression. JAMA 1992;267:1783-7.
47. Long TD, Kathol RG. Critical review of data supporting affective disorder caused by nonpsychotropic medication. Ann Clin Psychiatry 1993;5:259-79.
48. Yudofsky SC. β-Blockers and depression: the clinician's dilemma. JAMA 1992;267:1826-7.
49. Barron HV, Viskin S, Lundstrom RJ, et al. Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization. Arch Intern Med 1998;158:449-53.
50. Martinez M, Agusti A, Arnau JM, Vidal X, Laporte JR. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period. Eur J Clin Pharmacol 1998;54:203-8.
51. Iezzoni LI, Burnside S, Sickles L, Moskowitz MA, Sawitz E, Levine PA, Coding of acute myocardial infarction. Clinical and policy implications. Ann Intern Med 1988;109:745-51.
52. Assaf AR, Lapane KL, McKenney JL, Carleton RA. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med 1993;329:931-5.
53. Lernfelt B, Landahl A, Svanborg A. Coronary heart disease at 70, 75, and 79 years of age: a longitudinal study with special reference to sex differences and mortality. Age Ageing 1990;19:297-303.
54. Gillum RF, Feinleib M. Coronary heart disease in the elderly. Compr Ther 1988;14:66-73.
55. Bild DE, Fitzpatrick A, Fried LP, et al. Age-related trends in cardiovascular disease morbidity and physical functioning in the elderly: the cardiovascular health study. J Am Geriatr Soc 1993;41:1047-56.
56. Gambassi G, Lapane K, Sgadari A, et al. Prevalence, clinical correlates and treatment of hypertension in institutionalized elderly. Arch Intern Med 1998;158:2377-85.